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Abstract
Background: Some functions of 4.1R in non-erythroid cells are directly related with its distinct sub-cellular
localisation during cell cycle phases. During mitosis, 4.1R is implicated in cell cycle progression and spindle pole
formation, and co-localizes with NuMA1. However, during interphase 4.1R is located in the nucleus and only
partially co-localizes with NuMA1.
Results: We have characterized by NMR the structural features of the C-terminal domain of 4.1R and those of the
minimal region (the last 64 residues) involved in the interaction with NuMA1. This subdomain behaves as an
intrinsically unfolded protein containing a central region with helical tendency. The specific residues implicated in
the interaction with NuMA1 have been mapped by NMR titrations and involve the N-terminal and central helical
regions. The segment of NuMA1 that interacts with 4.1R is phosphorylated during mitosis. Interestingly, NMR data
indicates that the phosphorylation of NuMA1 interacting peptide provokes a change in the interaction mechanism.
In this case, the recognition occurs through the central helical region as well as through the C-terminal region of
the subdomain meanwhile the N-terminal region do not interact.
Conclusions: These changes in the interaction derived from the phosphorylation state of NuMA1 suggest that
phosphorylation can act as subtle mechanism of temporal and spatial regulation of the complex 4.1R-NuMA1 and
therefore of the processes where both proteins play a role.
Background
The protein 4.1R was originally described as a compo-
nent of red blood cells essential in the maintenance of
cellular shape and integrity. In these cells, protein 4.1R
is an 80 kDa component that anchors the spectrin-actin
network to the overlaying lipid bilayer through interac-
tions with cytoplasmic domains of transmembrane pro-
teins [1,2]. In non-erythroid cells the expression pattern
of protein 4.1R is more complex and multiple isoforms
of 4.1R are mainly produced as a result of extensive
alternative splicing of the 4.1R pre-mRNA [3-7]. Non-
erythroid 4.1R has been found adjacent to the cellular
membrane but also in different intracellular regions
such as the nucleus or the centrosome indicating that
4.1R possesses a wider range of functions beyond that of
maintaining the cell shape [2,8]. It has been described
that 4.1R is essential for microtubule dynamics, mainte-
nance of centrosome integrity, cell cycle progression
and correct formation of mitotic spindles among others
[9]. 4.1R is an adaptor protein and these functions may
be related with its capacity to interact with different
partners. In this sense, it could serve to integrate centro-
somal components and thus be critical for some centro-
somal functions, such as regulation of polarity,
intracellular transport, etc. Protein 4.1R interacts with
NuMA1 [10] and 4.1R depletion provokes mislocaliza-
tion of NuMA1 [9]. The changes in the expression pro-
file of both proteins alter the cell cycle and perturb cell
mitotic spindles in the same way [9-12]. This fact sug-
gests that the 4.1R and NuMA1 functions related to cell
cycle progression and spindle pole integrity might be a
consequence of their interaction.
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Prototypical non-erythroid protein 4.1R is constituted
by 5 domains (Figure 1), 1) Head Piece (HP); 2) 4.1,
Ezrin, Radixin, Moesin (FERM); 3) 16 kDa; 4) Spectrin/
Actin Binding domain (SAB); and 5) C-terminal domain
(CTD) [13,14]. In turn, NuMA1 has three domains
(Figure 1), two terminal domains (1-207 and 1729-2115)
and a central long coiled-coil region [15]. The interaction
between 4.1R and NuMA1 occurs between the C-term-
inal domains of both proteins. The interacting regions
were mapped by yeast two hybrid assay and the minimal
interacting epitopes were defined as the last 64 amino
acids for 4.1R and the region comprised by the amino
acids in positions 1788 to 1808 for NuMA1 [10] (Figure
1). In vivo, during mitosis, 4.1R and NuMA1 co-localize
in the centrosome where both proteins have been found
to be phosphorylated [16-18] but in other cell cycle steps,
e.g. in interphase, 4.1R immunoreactivity is diffused in
the nucleus and cytoplasm and concentrated in nuclear
speckles enriched in splicing factors [19]. Nuclear protein
4.1R only partially co-localizes with nuclear NuMA1 [10].
Whether or not these two proteins interact in the
nucleus or in the centrosome, remains to be established.
Similarly, there are a number of open questions: i) is a
control of the interaction of 4.1R and NuMA necessary
for their centrosomal location and therefore for the cell
cycle progression?, ii) is the fine interaction regulated at
each moment of the cell cycle?, iii) how does phosphory-
lation affect the interaction of both proteins? Here, our
goals are to characterize at high resolution the minimal
region within the 4.1R C-terminal domain involved in
the interaction with NuMA1 and to determine whether
phosphorylation in the interacting regions regulates the
4.1R-NuMA1 interaction.
Results
CD and NMR study of the C-terminal domain of 4.1R
The complete C-terminal domain of 4.1R expressed well
and was soluble at pH 6.5. The CD spectrum of the
domain (Figure 2A) indicates that the protein has a high
level of secondary structure (12% a-helix; 43% b-strand
and 45% random coil). This result agrees with the pro-
portions obtained from the secondary structure predic-
tor Jpred [20] (11% a-helix; 32% b-strand; 57% random
coil). However, the 15N-HSQC spectrum (Figure 2C),
shows a lack of signal dispersion typical of unstructured
protein sequences. Besides this poor dispersion, the
widths of the NMR signals are not uniform, some of
them are very broad and others are very sharp. In addi-
tion, the number of signals in the spectrum is less than
what is expected for this domain indicating that differ-
ent dynamic regimes due to chemical or conformational
exchange are present. All these data suggest the pre-
sence of possible aggregation states that makes impossi-
ble the NMR assignment of the complete C-terminal
domain of 4.1R. Therefore, we focussed on a shorter
form of the C-terminal domain of 4.1R.
NMR Structural studies of the subdomain 4.1R-CTD64 and
of NuMA1 peptides
A shorter form of the C-terminal domain of 4.1R con-
taining the last 64 amino acids (4.1R-CTD64), which
has been reported to be the minimal unit capable of
interacting with NuMA1 [10], was produced.
The 15N-HSQC spectrum of 4.1R-CTD64 shows
poor signal dispersion, suggesting the absence of pre-
ferred structure in agreement with the CD data (Figure
2B). In contrast to the full length C-terminal domain,
the majority of the 4.1R-CTD64 NMR signals have
similar widths and the number of cross peaks matches
that expected on the basis of the 4.1R-CTD64
sequence. In these conditions, the complete assignment
of its backbone was carried out (Figure 2D). The ana-
lysis of the conformational chemical shifts (Δδ13C =
δ13C, experimental- δ
13C, random coil, ppm) [21], shows
consistent positive or negative values, for Ca and Cb
respectively, between residues 28 and 44 compatible
with the presence of an a-helix conformation in this
region (Figure 3A and 3B). The mean helix percentage
for the segment 28-44, calculated on the bases of the
Δδ13Ca values is 15% [22]. This experimental data is in
Figure 1 Schematic representation of the different domains of 4.1R and NuMA1. Coloured segments correspond to the minimal
interacting regions and the amino acid sequences of the 4.1R subdomain and NuMA1 peptides used in this study are shown. Nomenclature of
4.1R domains: HP: Head Piece; FERM: 4.1, Ezrin, Radixin, Moesin; 16 kDa: 16 kDa; SAB: Spectrin/Actin Binding domain; CTD: C-terminal domain.
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the range of that predicted by AGADIR [23], a mean
helix population of 9% in this region (Figure 3C).
The 1H NMR spectra (COSY, TOCSY and NOESY) of
all NuMA1 peptides (NuMA1 overlapping, N1O;
NuMA1 Interacting, N1I and phosphorylated NuMA1
Interacting, N1IP) (pH 4, 5°C), were analysed and
assigned. The deviation of the 1H conformational chemi-
cal shifts [21] of the three species are all < 0.1 ppm,
except for those shown by two residues in the control
peptide (N1O) and one in the non-phosphorylated pep-
tide (N1I) (Figure 4). This indicates that the peptides do
not have any significant tendency to adopt secondary
structure. Figure 5A shows the differences in the chemi-
cal shifts of HN and Ha protons between the phos-
phorylated (N1IP) and non-phosphorylated peptide
(N1I). As expected, the largest chemical shift differences
are observed for T6 (the phosphorylated amino acid)
and adjacent residues, but significant changes are also
found for R10 and R12. All other NMR signals show a
remarkably good superposition, as seen in the TOCSY
and NOESY spectral region shown in Figure 5B.
4.1R-CTD64 has a theoretical pI of 5.2 meanwhile the
NuMA1 interacting peptide (N1I) has a pI of 11.8. To
assess if the difference of charge is leading to their
Figure 2 CD and 1H-15N HSQC spectra of 4.1R domains. A: CD spectra of the C-terminal domain of 4.1R. B: CD spectra of the 4.1R-CTD64
domain of 4.1R. Samples for CD were 5 mM in 10 mM Na2HPO4 at pH 6.5 (4.1R C-terminal domain) or pH 4.9 (4.1R-CTD64). C:
1H-15N HSQC
spectra of the C-terminal domain of 4.1R at pH 6.5 (0.6 mM protein in H2O 90%/D2O 10% at pH 6.5). D:
1H-15N HSQC spectra of the 4.1R-CTD64
domain at pH 4.9 (0.1 mM protein in Na2HPO4 100 mM in 90% H2O/10% D2O pH4.9) with signal assignments. Note that the spectral width in D
is smaller than in C to facilitate the visualization of the assignments.
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Figure 3 Tendency of 4.1R-CTD64 to adopt an a-helix conformation. A: Conformational Δδ13Ca (Δδ13Ca = δ13Ca, experimental- δ13Ca, random coil,
ppm) chemical shifts as a function of sequence. Positive values indicate a-helix structure. B: Conformational Δδ13Cb (Δδ
13Cb = δ
13Cb, experimental-
δ13Cb, random coil, ppm) chemical shifts as a function of sequence. Negative values indicate a-helix structure. C: Theoretical prediction of helical
percentage at 5°C and pH 5.0 by AGADIR [23] as a function of residue number.
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interaction via electrostatic forces, we first titrated 4.1R-
CTD64 with NuMA1 overlapping (N1O) peptide, which
overlaps with N1I and has a similar pI (11.4). We added
up to 20:1 N1O to 4.1R-CTD64, in the same conditions
used for N1I (see below), without changes in the 15N-
HSQC spectrum of the domain (Figure 6A). In all cases
titrations were followed by chemical shift perturbation
analysis [24,25].
First attempts to titrate 4.1R-CTD64 with N1I were
made at pH 4, where both 4.1R-CTD64 and N1I are
completely soluble. In these conditions, even at an
excess of N1I:4.1R-CTD64, 20:1, just slight changes in
the NMR spectra were detected, indicating absence of
interaction between both species in these conditions
(Figure 6B).
Taking into account that at pH 4 Asp and Glu resi-
dues are partially titrated, and that the electrostatic
forces can affect their implication in the interaction,
titrations were repeated at pH 4.9, where the acid resi-
dues are almost completely in their carboxylate state
and 4.1R-CTD64 is still soluble enough to yield a fair
spectrum. In these conditions, changes in the 15N-
HSQC spectrum of 4.1R-CTD64 were detectable even at
5:1 of N1I:4.1R-CTD64 (Figure 7). The residues of 4.1R-
CTD64 participating in the interaction (T1, T4, T6, I11,
E17, R19, V21, I22, T23, G24, I28, D29, D31, Q32, V33,
L34, A37, I38, K39, A41, K42, H45, H56) are mainly
concentrated in the N-terminal and central portion of
the domain except for H56, and no effect was detected
for the last 19 amino acids (Figure 8).
Proteomic studies show that NuMA1 is phosphory-
lated during mitosis at position 1790 [16], which corre-
sponds to T6 in the sequence of the N1I peptide. To
evaluate the effect of the phosphorylation of NuMA1 in
the interaction, 4.1R-CTD64 at pH 4.9 was titrated with
phosphorylated NuMA1 peptide (N1IP). The changes
observed in the NMR spectra indicate the interaction of
the peptide with many residues of 4.1R-CTD64 (T4, I22,
T23, G24, D29, D31, V33, L34, V35, A37, I38, K39,
A41, K42, H45, S49, V50, T51, V53, E58, T59, E60, I61,
A62). Many of them, as in the case of the titration with
the non-phosphorylated N1I, are in the central region of
the domain but alterations in the position of nuclei
belonging to some C-terminal residues were also
detected. The disappearance of specific signals in the
15N-1H HSQC spectrum takes place at similar peptide
to 4.1R-CTD64 ratios in both cases.
In short, the titrations with both peptides provoke
changes in 15 common amino acids, mainly sited in the
central region of 4.1R-CTD64. Interestingly, the non
common affected residues are located in the opposite
ends of the domain. Thus, the interaction with N1I,
exclusively affects 8 additional residues in the N-term-
inal portion of 4.1R-CTD64 whereas the titration with
N1IP, perturbs other 11 residues which are exclusively
located in the C-terminal region of 4.1R-CTD64.
Discussion
The NMR chemical shift data of 4.1R C-terminal
domain presented here indicates that the domain is
Figure 4 Conformational shifts for the Ha protons of NuMA1 peptides. Histogram showing the conformational shifts for the Ha protons
(Δδ = δexperimental - δrandom coil, ppm) of control peptide (N1O, grey bars), non-phosphorylated NuMA peptide (N1I, red bars) and phosphorylated
NuMA peptide (N1IP, green bars) as a function of peptide sequence. The Δδ range indicative of random coil peptides is shown by lines at 0.1
and -0.1 ppm. N1O: sequence 1776-1796 of NuMA1, N1I: sequence 1785-1810 of NuMA1, N1IP: same as N1I but phosphorylated in T6
corresponding to T1790 of NuMA1.
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Figure 5 NMR results for N1I and N1IP. A) Histogram showing the chemical shift differences between non-phosphorylated (N1I) and
phosphorylated NuMA1 peptide (N1IP) for the NH (black bars) and Ha (grey bars) protons as a function of peptide sequence. B) TOCSY and
NOESY spectral regions of non-phosphorylated (red contours) and phosphorylated (green contours) NuMA1 peptides. Signals that change upon
phosphorylation are indicated in both spectra. Signal labels are red for the non-phosphorylated peptide, green for the phosphorylated peptide
and grey for those signals that does not change with phosphorylation. Intrarresidual signals are labelled with the proton involved in the
interaction with the corresponding amide HN (greek symbol), the one letter amino acid code and the residue number. In the NOESY spectra,
interresidual signals are labelled with two numbers corresponding to the aliphatic proton of residue i and the HN proton of residue i+1. N1I:
sequence 1785-1810 of NuMA1, N1IP: same as N1I but phosphorylated in T6 corresponding to T1790 of NuMA1.
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intrinsically unstructured. Intrinsically unstructured pro-
teins (IUP) and domains have gained prominence in
recent years due to their importance in regulation, sig-
nalling, and other processes where a subtle and precise
control is necessary [26]. In this regard, 4.1R and
NuMA1 are involved in cell cycle control and mitosis,
two processes where fine temporal and spatial coordina-
tion is needed and where a high number of natively
unstructured proteins has been identified [26]. The lack
of structure provides functional advantages as binding
promiscuity [27], moonlighting [28], decoupled specifi-
city and affinity [29], the possibility to be protein inter-
action hubs [30], accessibility to post-translational
modifications [31] or a higher capture radius and high
speed of the interaction even at low concentrations [32]
that can be essential for the functions of the 4.1R
C-terminal domain in cell cycle and mitosis.
This lack of preferred three dimensional structure, as
seen by NMR, is compatible with the CD data showing
that the C-terminal domain of 4.1R conserves elements
of secondary structure. This is not an uncommon situa-
tion for unstructured proteins were the grade of disor-
der can be very variable and many states, from
conformational ensembles of completely unstructured
proteins to mostly folded proteins with disorder only in
small regions have been described. Between these two
extremes all intermediate situations can be found [33].
Additionally, the absence of some expected signals and
the different signal widths as observed in the 15N-HSQC
spectrum of the C-terminal domain of 4.1R can be
attributed to aggregation processes. Predictions of aggre-
gation made by TANGO [34] indicate short regions
with low tendency for b-aggregation and no detectable
a-aggregation. These processes could increase at the
mM concentrations used in NMR spectroscopy. From a
solution NMR perspective, a protein or protein domain
associated forming large entities tumbles as part of a
large complex, which results in signal broadening and
poor sensitivity. In the same way, the different regions
of an unstructured protein being implicated in
Figure 6 Titration of 4.1RCTD64 with N1O peptide at pH 4.9 and with N1I at pH 4.0. Titration of 15N labelled 4.1R-CTD64 followed by 1H-
15N HSQC NMR spectra at 25°C. A: Titration with N1O (sequence 1776-1796 of NuMA1) at pH 4.9. B: Titration with N1I (sequence 1785-1810 of
NuMA1) at pH 4.0. In both cases black lines belong to the NMR spectra of 4.1R-CTD64 alone and red lines to the spectra in presence of NuMA1
peptides (ratio 1:20).
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aggregation have broad peaks that can be unobservable
due to the large molecular weight dynamic regime and/
or possible intermediate exchange regime.
In any case, these problems preclude the assignment
of the complete C-terminal domain of 4.1R, essential for
subsequent studies of interaction by NMR. As a conse-
quence, we centred our study on a shorter form con-
taining only the last 64 amino acids, 4.1R-CTD64, which
has been defined as the minimal subdomain able to
interact with NuMA1 [10]. The NMR, as well as the CD
data, indicate that the 4.1R-CTD64 subdomain is also
unstructured but, based on the Δδ13Ca, there is a region
(from 28 to 44) with tendency to form an a-helix in
aqueous solution.
By using the chemical shift mapping methodology
[24,25], we have determined that 4.1R-CTD64 interacts
with NuMA1 peptide (N1I) at pH 4.9 through the
N-terminal residues as well as the central region. Inter-
estingly, this central region coincides with the segment
which has tendency to be a-helical. The NMR assign-
ment of 4.1R-CTD64 at pH 3 and pH 4.9 shows that
the tendency to form a-helix in the region 28 to 44 is
Figure 7 Detail of the 1H-15N HSQC spectra corresponding to the titrations of 4.1RCTD64 with NuMA1 peptides at pH 4.9. A and B in
one hand and C and D in the other show the same regions of the spectra. A and C: Spectra of 4.1R-CTD64 alone (black) or in presence of 20 to
1 ratio of N1I (sequence 1785-1810 of NuMA1) (blue). B and D: Spectra of 4.1RCTD64 alone (black) or in presence of 20 to 1 ratio of N1IP (N1I
phosphorylated) (red). Note the drastic changes in the signal intensity of T51 and T59 after titration with N1IP, of I11 after titration with N1I, or
of I38 after titration with both peptides.
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almost the same in both conditions, indicating that the
observed a-helix population does not depend on the
protonation state of the carboxylate groups. However,
the interaction between 4.1R-CTD64 and N1I is strongly
affected by the charges present in the peptide, as no
interaction was detected during the titration of 4.1R-
CTD64 with N1I at pH 4 but changes are important at
pH 4.9.
Regarding the nature of the forces driving the interac-
tion, the electrostatic charges seem not to be determi-
nant because the overlapping peptide N1O, which
shares the N-terminal sequence with N1I and has a
similar pI, does not interact with 4.1R-CTD64. This also
suggests that the C-terminal region of N1I is key for the
interaction. This region of N1I contains a high number
of hydrophobic residues which have been reported to be
preferentially used in interactions by unstructured pro-
teins [35].
Proteomic studies show that NuMA1 is phosphory-
lated at position 6 of N1I during mitosis (position 1790
in complete NuMA1) [16]. During this phase of the cell
cycle, NuMA1 and 4.1R co-localize in the centrosome
while 4.1R only partially co-localizes with NuMA1 at
interphase [10]. Our data show that the interaction of
4.1R-CTD64 with the N1I peptide differs depending on
the phosphorylation state. The same residues of the cen-
tral region of 4.1R-CTD64 interact with both peptides,
but there are differences in the participation of both ter-
mini: residues of the N-terminal portion of 4.1R-CTD64
interact with the non-phosphorylated N1I while residues
from the C-terminal region are affected during the titra-
tion with the phosphorylated N1IP. In both cases, no
differences in the regime of interaction are detected
regarding to its affinity.
Two principal kinds of non-mutually exclusive ele-
ments of interaction have been postulated in IUPs:
molecular recognition features and preformed elements.
Molecular recognition features are short regions that
undergo a disorder to order transition that is stabilized
by binding to their partners [36]. On the other hand,
preformed elements are elements of secondary structure
which are present in the free IUP form that usually are
the first interacting element, and that maintain their
structure after interaction [37]. In our case, the 28-44
region shares characteristics of both kinds of recognition
elements as a preformed structure, the a-helix, is pre-
sent though not 100% populated. The fact that the same
residues in this central region are affected in both titra-
tions suggests that the phosphorylated residue of
NuMA1 is not directly contacting with the a-helix but
more probably with the C-terminal portion of 4.1R-
CTD64, where the residues exclusively affected during
the titration with N1IP are located.
The identification of the elements responsible for the
interactions in unstructured proteins is of major impor-
tance because even subtle differences are able to pro-
duce key changes. It has been described that the initial
steps of these interactions are driven by just a few num-
ber of residues, even with a low affinity, and then the
remaining regions start to contact with the partner
[32,36,37]. In this context it is not difficult to think that
even minor differences in the recognition are important
enough to drive a completely different interacting sur-
face. Related to this, a possibility is that after the initial
contact by an element of interaction, the unstructured
protein can adopt different structural dispositions that
can produce different effects such as activation or inhi-
bition of the partner [28]. Clearly, this can be the case
for the interaction of 4.1R-CTD64 and N1I and N1IP.
From our data we cannot deduce if 4.1R and NuMA1,
which co-localize at the centrosome and partially
co-localize in the nucleus, are interacting at both intra-
cellular sites, nucleus and centrosome, or only at the
centrosome. A scenario compatible with our data is that
both proteins bind each other in the nucleus leaving the
phosphorylatable threonine accessible to protein kinases.
NuMA1 could be phosphorylated previously to mitosis,
which can trigger the reorientation or reorganization of
Figure 8 Representation of the interaction of 4.1R-CTD64 with NI1 and NI1P peptides from NuMA1. Graphic representation of the
interaction of 4.1R-CTD64 with NI1 (sequence 1785-1810 of NuMA1) and NI1P (N1I phosphorylated) peptides from NuMA1. Residues coloured in
blue indicate changes after titration with N1I. Residues coloured in red indicate changes after titration with N1IP. Residues in both colours
indicate changes after both titrations. The region with a-helix propensity as seen by NMR chemical shift analysis is represented with undulating
lines within an orange cylinder.
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both proteins forming the complex. In this new state
they could participate in spindle pole formation. The
two different ways of interaction may also be related
with different functions, in a process of moonlighting
consequence of the state of phosphorylation. A similar
kind of process has been described in IUPs [28], like for
example for the IUP Cystic Fibrosis Transmembrane-
conductance Regulator (CFTR) which interacts with the
chloride channel and activates or inhibits it as a func-
tion of its phosphorylation state [38].
Conclusions
In conclusion, the C-terminal domain of 4.1R, as well as
the subdomain 4.1R-CTD64, have all features of intrinsi-
cally unstructured domains. By using the NMR data pre-
sented here, we were able to identify the residues
involved in the interaction with N1I of NuMA1. Even
more, we have found that 4.1R-CTD64 binds the phos-
phorylated form of N1I (N1IP) in a different way. Tak-
ing into account that the phosphorylated form of
NuMA1 is detected in mitosis, where both proteins may
interact, we can suggest that the changes produced by
phosphorylation modulate the interaction and therefore
the progression of cell cycle and the spindle pole forma-
tion. Other phosphorylations, even in regions different
from this one [17] can aid the more precise modulation
of its interaction. In any case, the results presented here
open the door to study the interaction between the
complete proteins or functional domains regarding the
influence of the phosphorylation state, and how the
reorientation of both molecules as a consequence of the
phosphorylation affects their function in mitosis.
Methods
Protein production and purification
A plasmid containing the complete 4.1R sequence [39]
was used as template in PCRs specific for 4.1R C-term-
inal domain (last 174 amino acids of human 4.1R) and
4.1R-CTD64 (last 64 amino acids): (TQITKTVKGGISE-
TRIEKRIVITGDADIDHDQVLVQAIKEAKEQHPDM
SVTKVVVHQETEIADE). PCRs (30 cycles 1 min 95°C; 1
min 52°C; 1 min 72°C) were carried out with the Hot
start KOD polymerase (Merck, Germany) according
manufacturer recommendations using 5’-GCGGCGAT-
GAGTGTCTCTGCATGGAGTCTGTACCAGAA-3’ (for
the complete C-terminal domain) or 5’-GCGCATAT-
GACTCAAATTACCAAGACTGT-3’ (for 4.1R-CTD64)
and 5’-GGGCTCGAGTCATTACTCATCAGCAAT
CTCGGT-3’ (for both fragments) as primers. PCR pro-
ducts were sequentially digested for 3 hours at 60°C
with BtgZI and then with BamHI at 37°C (complete
domain) or simultaneously at 37°C with NdeI and
BamHI (64 amino acids subdomain). The digested frag-
ments were cloned in a modified pET15b vector with
the thrombin cleavage site replaced with a TEV protease
cleavage site.
(His)6-tagged proteins were expressed in E. coli strain
BL21 (DE3). Production was made by High Cell Density
Fermentation [40] in 700 ml of HCDF medium in a Bio-
flo 110 fermentor (New Brunswick Scientific, NJ).
Labelled proteins were obtained using HCDF medium
containing 15NH4Cl and
13C-u-glucose as exclusive
nitrogen and carbon sources, respectively. Collected bac-
teria were resuspended in 40 ml of NaH2PO4 50 mM
pH 7, NaCl 200 mM containing complete protease inhi-
bitor without EDTA (Roche, Germany) and lysed by
sonication. Lysates were purified by nickel affinity chro-
matography and fractions were eluted with lysis buffer
containing 300 mM imidazole. Eluates were dialyzed
against 50 mM NaH2PO4 pH 7, 200 mM NaCl and 10
mM PMSF and digested with TEV protease overnight at
4°C. The proteins were subjected to a second purifica-
tion step by nickel affinity chromatography and the
overexpressed proteins lacking (His)6-tag were collected
from the throughput and re-dialyzed against appropriate
buffers for the subsequent experiments.
Peptides
Synthetic peptides NuMA1 interacting (N1I, comprising
residues 1785-1810 of NuMA1), Ac-DSGRKTRSAR
RRTTQIINITMTKKLD-NH2, and phosphorylated
NuMA1 interacting (N1IP) peptides, Ac-DSGRKT(p)
RSARRRTTQIINITMTKKLD-NH2 were obtained from
Caslo (Denmark). The NuMA1 overlapping peptide
(N1O, encompassing residues 1776-1796 of NuMA1)
Ac-LDSLGDVFLDSGRKTRSARRR-NH2 was synthesized
on an automated multiple peptide synthesizer (Multipep,
Intavis AG, Koln, Germany) using the solid-phase pro-
cedure and standard Fmoc chemistry [41]. Side chain
protecting groups were as follows: OtBu (D), tBu (S, T),
Pbf (R) and Boc (K). After synthesis, protecting side
chain groups were removed, and the peptide was
cleaved from the resin following the method of King et
al. [42]. Peptides were purified by high-performance
liquid chromatography (HPLC) on a DeltapaK C18 (7,8
× 300 mm) semi-preparative column (Waters). Peptide
homogeneity and integrity were confirmed by analytical
HPLC, amino acid analysis (Beckman 6300 amino acid
analyzer, after acid hydrolysis in a N2 atmosphere for 18
h at 110°C), mass spectrometry (4800 Applied Biosys-
tems, MALDI-TOF-TOF, matrix-assisted laser deso-
rption-ionization time-of-flight mass spectrometer) and
by NMR analysis.
CD spectra
CD spectra were obtained in a JASCO J-810 spectropo-
larimeter equipped with a Peltier type cell holder. Pro-
tein concentration were in all cases 5 μM (1-mm
Treviño et al. BMC Biochemistry 2010, 11:7
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pathlength; far-UV region). Each spectrum (0.2-nm
intervals) was the average of 3-4 measurements with dif-
ferent samples (each of them the average of 4 scans)
performed at a rate of 20 nm min-1 using a response
time of 2 s and a bandwidth of 1 nm. The temperature
was kept constant at 20°C. The buffer contribution to
the CD spectrum was subtracted from the experimental
data, and the corrected ellipticities were converted to
mean residue ellipticities. Samples contained 10 mM
Na2HPO4 at pH 6.5 (4.1R C-terminal domain) or pH 4.9
(4.1RCTD64).
NMR spectra acquisition and analysis
Samples for NMR were prepared at 0.6 mM in H2O
90%/D2O 10% at pH 6.2 (4.1R C-terminal domain), at
0.1 mM in Na2HPO4 100 mM in 90% H2O/10% D2O
pH 3.0, 4.0 or 4.9 (4.1R-CTD64) or at 1 mM in 90%
H2O/10% D2O pH 4.0 for N1I, N1IP, and NIO. For the
titration, peptides were prepared in the same buffer as
the 4.1R-CTD64 sample. All samples contained sodium
4,4-dimethyl-4-silapentane-1-sulfonate (DSS) as the che-
mical shift reference. Spectra were acquired on a Bruker
Avance 800 MHz spectrometer equipped with a z-gradi-
ent cryoprobe. 3D HNCA, HN(CO)CA, CBCANH and
CBCA(CO)NH spectra were acquired for the assignment
of the backbone of 4.1R-CTD64 at pH 3.0. The standard
assignment methodology was followed [43]. All assign-
ments were transferred to the pH 4.9 conditions and the
correct assignment was confirmed using a set of b- and
g-carbon edited 1H-15N spectra. These experiments clas-
sify peaks according to the number of b and g hydro-
gens. Compared to a standard HSQC spectra, these
NMR experiments yield a series of HSQC sub-spectra
with greatly reduced overlap as peaks are classified as a
function of the type of amino acid as well as the type of
the preceding one [44].
For NuMA1 peptides, 2D COSY, TOCSY and NOESY
spectra were acquired and assigned following standard
methods [45].
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